Publication | Open Access

Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options

Therapeutic OptionsTumor BiologyHematological MalignancyMedicineImmunologyCancer GenomicsMutation PatternsMolecular DiagnosticsRadiation OncologyCancer ResearchDrug Profiling